United Kingdom experience with presymptomatic testing of individuals at 25% risk for Huntington's disease

Citation
Cm. Benjamin et A. Lashwood, United Kingdom experience with presymptomatic testing of individuals at 25% risk for Huntington's disease, CLIN GENET, 58(1), 2000, pp. 41-49
Citations number
26
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Molecular Biology & Genetics
Journal title
CLINICAL GENETICS
ISSN journal
00099163 → ACNP
Volume
58
Issue
1
Year of publication
2000
Pages
41 - 49
Database
ISI
SICI code
0009-9163(200007)58:1<41:UKEWPT>2.0.ZU;2-R
Abstract
Between 1994 and 1998, the 23 UK genetics departments, which form the UK Hu ntington's Disease Consortium, have undertaken 161 direct mutation adult pr edictive tests on individuals whose at-risk parent was alive or had died wi thout showing signs of Huntington's disease (HD) (5.7% of total UK tests). This study describes the number of requests for 25% risk predictive testing for HD in 1994 (the first year in which direct testing was available in th e UK), and also a descriptive survey of the first 85 tests. In total, 85 tests were performed in the first 2 years of direct mutation t esting, ten (11.8%) tests were mutation positive, 73 (85.9%) were negative and two (2.3%) were equivocal. The at-risk parent was alive in 54 (63.5%) c ases. Four of the ten mutation positive candidates had parents who were ali ve and therefore received a prediction through their child. All centres inc luded a discussion about the effect of testing on the 50% at-risk parent an d all offered to see the parent for counselling. Of the 87 applicants for t esting during 1994, 31 (35.6%) withdrew, this is higher than the 25% withdr awal rate for the 50% risk candidates. The candidates who withdrew were sig nificantly younger and had more parents who were alive than those who conti nued with testing. Seven of the 31 candidates who withdrew from testing had at-risk parents who decided to be tested in the first instance. During the counselling process, issues were raised relating to pre-test agreements an d family secrecy. This study indicates the importance of pre-test counselli ng and the involvement of the parent in the counselling process. 25% risk t esting for IID is now being offered in the majority of UK centres. As more genes are identified for late-onset conditions, it is important that the co mplexities of 25% risk testing for late-onset conditions are not underestim ated, This limited survey does not investigate how individual families cope with the psychological and social issues raised by this study and further research in this area is needed.